Table 2.
Time-point | Week 26 | Week 52 | Week 104 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Group | Control | Low-dose | High-dose | Control | Low-dose | High-dose | Control | Low-dose | High-dose | |
Number of rats examined | 5 | 5 | 5 | 5 | 4 | 4 | 27 | 26 | 24 | |
Lung | Accumulation, alveolar macrophage | 1 | 5* | 5* | 0 | 4* | 4* | 6 | 26* | 24* |
[0.05] | [1.34*] | [1.86*] | [0] | [1.74*] | [2.63*] | [0.08] | [2.55*] | [2.84*] | ||
Focal fibrosis, alveolar wall | 0 | 5* | 5* | 0 | 4* | 4* | 0 | 26* | 24* | |
[0] | [1.42*] | [1.86*] | [0] | [1.65*] | [2.56*] | [0] | [2.59*] | [3.19*] | ||
Granulomatous change | 0 | 3 | 5* | 0 | 4* | 4* | 0 | 26* | 24* | |
[0] | [0.10] | [1.12*] | [0] | [0.86*] | [1.71*] | [0] | [1.31*] | [2.52*] | ||
Reactive alveolar hyperplasia | 0 | 5* | 5* | 0 | 4* | 4* | 0 | 26* | 24* | |
[0] | [0.61*] | [1.39*] | [0] | [1.60*] | [2.04*] | [0] | [2.43*] | [2.60*] | ||
Bronchiolar hyperplaisa (bronchiolization) | 0 | 4*4a | 0 | 0 | 1 | 4* | 1 | 26* | 24* | |
[0] | [0.80*] | [0.20] | [0] | [0.25] | [1.00*] | [0.04] | [2.19*] | [2.92*] | ||
Bronchioloalveolar hyperplasia | 0 | 1 | 0 | 2 | 0 | 0 | 6 | 16* | 22* | |
[0] | [0.20] | [0] | [0.40] | [0] | [0] | [0.46] | [1.67*] | [2.50*] | ||
Atypical hyperplasia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 10* | |
[0] | [0] | [0] | [0] | [0] | [0] | [0] | [0.43*] | [0.92*] | ||
Pleura | Infiltration of inflammatory cells | 0 | 3 | 4* | 0 | 4* | 4* | 0 | 24* | 23* |
[0] | [0.80] | [1.00*] | [0] | [0.75*] | [1.75*] | [0] | [1.52*] | [1.92*] | ||
Focal fibrosis | 0 | 2 | 4* | 0 | 4* | 4* | 0 | 26* | 24* | |
[0] | [0.60] | [1.40*] | [0] | [1.25*] | [1.75*] | [0] | [2.38*] | [2.75*] | ||
Mesothelial hyperplasia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9* | 17* | |
[0] | [0] | [0] | [0] | [0] | [0] | [0] | [0.62*] | [1.42*] |
Values show the number of animals bearing the lesion
Values in square brackets are the average severity grades in all examined animals;
Grade: 0, no/minimal change; 1, slight; 2, moderate; 3, marked; 4, severe
The column “week 104” includes animals that died or were euthanized before the termination
Animals bearing large granular lymphocytic leukemia (LGL) were excluded (3, 3, and 4 animals in the control, low-dose, and high-dose groups, respectively)
*Significantly different from a corresponding control group (incidence, Fischer's exact test; severity score, Steel's test)